Christopher Ray Aker's Net Worth
$46 Thousand
Who is Christopher Ray Aker?
Christopher Ray Aker does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Regulus Therapeutics Inc..
SEC CIK
Christopher Ray Aker's CIK is 0001762611
Past Insider Trading and Trends
2019 was Christopher Ray Aker's most active year for acquiring shares with 5 total transactions. Christopher Ray Aker's most active month to acquire stocks was the month of December. 2019 was Christopher Ray Aker's most active year for disposing of shares, totalling 6 transactions. Christopher Ray Aker's most active month to dispose stocks was the month of April. 2022 saw Christopher Ray Aker paying a total of $0.00 for 550,000 shares, this is the most they've acquired in one year. In 2019 Christopher Ray Aker cashed out on 15,963 shares for a total of $18,002.88, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.48
Sr. VP & General CounselChristopher Ray Aker owns 10,056 units of Common Stock which is worth $14,882.88. From 2019 to 2024 Christopher Ray Aker acquired a total of 74,762 shares in Regulus Therapeutics Inc., Christopher also disposed a total of 28,903 shares of Regulus Therapeutics Inc. equalling to $31,158.36.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| -35.22% | -5.47K |
$1.19 | -$6,510.20 | 10.06K |
Jan 18
| |||
Form 4
| +263.22% | 11.25K |
—
|
—
| 15.52K |
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
| -2.02% | -860.00 |
$0.89 | -$765.40 | 41.75K |
Scheduled
|
May 17
| ||
Form 4
| -1.91% | -828.00 |
$1.72 | -$1,424.16 | 42.61K |
Scheduled
|
Feb 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| -3.29% | -876.00 |
$0.52 | -$456.48 | 25.76K |
Scheduled
|
Nov 16
| ||
Form 4
| -3.17% | -872.00 |
$0.61 | -$527.56 | 26.64K |
Scheduled
|
Aug 14
| ||
Form 4
| -3.20% | -909.00 |
$0.63 | -$569.76 | 27.51K |
Scheduled
|
May 15
| ||
Form 4
| -3.03% | -888.00 |
$0.83 | -$737.48 | 28.42K |
Scheduled
|
Feb 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
| -7.10% | -2.24K |
$0.97 | -$2,164.44 | 29.31K |
Scheduled
|
Jan 2
| ||
Form 4
| -2.57% | -833.00 |
$0.64 | -$533.12 | 31.55K |
Scheduled
|
Nov 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 4
| -6.76% | -2.35K |
$0.68 | -$1,601.61 | 32.38K |
Scheduled
|
Oct 1
| ||
Form 4
| -2.52% | -899.00 |
$0.55 | -$494.99 | 34.73K |
Scheduled
|
Aug 15
| ||
Form 4
| -5.88% | -2.23K |
$1.31 | -$2,918.09 | 35.62K |
Scheduled
|
Jul 1
| ||
Form 4
| +113.75% | 31.56K |
$1.41 | -$9,796.02 | 59.31K |
Scheduled
|
May 14 - May 15
| ||
Form 4
| -30.12% | -2.71K |
$0.98 | -$2,659.05 | 6.29K |
Scheduled
|
Apr 1
| ||
Form 4
| +910.08% | 25K |
—
|
—
| 27.75K |
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |